Capital Analysts LLC’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,500
| Closed | -$105K | – | 746 |
|
|
2020
Q3 | $105K | Hold |
1,500
| – | – | 0.01% | 307 |
|
|
2020
Q2 | $109K | Hold |
1,500
| – | – | 0.01% | 270 |
|
|
2020
Q1 | $69K | Hold |
1,500
| – | – | 0.01% | 294 |
|
|
2019
Q4 | $93K | Sell |
1,500
-230
| -13% | -$14.3K | 0.01% | 307 |
|
|
2019
Q3 | $73K | Hold |
1,730
| – | – | 0.01% | 325 |
|
|
2019
Q2 | $90K | Hold |
1,730
| – | – | 0.01% | 288 |
|
|
2019
Q1 | $95K | Hold |
1,730
| – | – | 0.01% | 268 |
|
|
2018
Q4 | $73K | Hold |
1,730
| – | – | 0.01% | 262 |
|
|
2018
Q3 | $121K | Hold |
1,730
| – | – | 0.01% | 232 |
|
|
2018
Q2 | $99K | Hold |
1,730
| – | – | 0.01% | 248 |
|
|
2018
Q1 | $95K | Hold |
1,730
| – | – | 0.01% | 249 |
|
|
2017
Q4 | $97K | Hold |
1,730
| – | – | 0.01% | 243 |
|
|
2017
Q3 | $106K | Hold |
1,730
| – | – | 0.01% | 236 |
|
|
2017
Q2 | $92.4K | Hold |
1,730
| – | – | 0.01% | 250 |
|
|
2017
Q1 | $83.5K | Hold |
1,730
| – | – | 0.01% | 228 |
|
|
2016
Q4 | $69K | Hold |
1,730
| – | – | 0.01% | 251 |
|
|
2016
Q3 | $83.8K | Buy |
+1,730
| New | +$83.8K | 0.02% | 220 |
|
|
2016
Q2 | – | Sell |
-1,730
| Closed | -$70.7K | – | 333 |
|
|
2016
Q1 | $70.7K | Hold |
1,730
| – | – | 0.01% | 242 |
|
|
2015
Q4 | $124K | Hold |
1,730
| – | – | 0.03% | 197 |
|
|
2015
Q3 | $101K | Hold |
1,730
| – | – | 0.02% | 228 |
|
|
2015
Q2 | $156K | Hold |
1,730
| – | – | 0.03% | 187 |
|
|
2015
Q1 | $137K | Hold |
1,730
| – | – | 0.03% | 183 |
|
|
2014
Q4 | $109K | Hold |
1,730
| – | – | 0.02% | 189 |
|
|
2014
Q3 | $89.9K | Hold |
1,730
| – | – | 0.02% | 198 |
|
|
2014
Q2 | $80.3K | Hold |
1,730
| – | – | 0.02% | 197 |
|
|
2014
Q1 | $69.1K | Buy |
+1,730
| New | +$69.1K | 0.02% | 204 |
|